Dendreon Corp fka DNDNQ

[Reters]

what makes DNDNQ interesting...
is we all have the chance at a 10x gain here from the ~.20cent levels based on some very conservative, realistic and reported numbers.
http://finance.yahoo.com/news/dendreon-announces-strong-commercial-start-133000809.html

Their main drug, not to mention the other casset patents, PHase2 drugs etc. revenues upwards of $300M per year. At a conservative 3x sales the bids should be in the $900M range.

$900M would result in convertable note holders being paid their $650M leaving the common folk aka us common shareholders roughly $2.24/share based on the 165M shares O/S.

Seems like a very good possibility their assets go for more then what they owe.

Auction is Feb 3rd, it gonna be a great show.

I have my tickets.